Sep 26, 2023 / 06:10PM GMT
Pete Stavropoulos - Cantor Fitzgerald LP - Moderator
Global Healthcare Conference, I'm Pete Stavropoulos, a biotech analyst with Cantor. With us, we have Pharvaris, and I'm now pleased to introduce the CBO, Morgan Conn. Well, welcome.
Morgan Conn - Pharvaris N.V. - Chief Business Officer
Thank you. Thanks for having us.
Pete Stavropoulos - Cantor Fitzgerald LP - Moderator
So let's start off with an introduction of the company for those who are less familiar.
Morgan Conn - Pharvaris N.V. - Chief Business Officer
Sure, thank you. So Pharvaris was started, gosh, or initiated about eight years ago now, with the idea of taking a proven mechanism in hereditary angioedema, which is the bradykinin inhibition of the bradykinin 2 receptor, and it would just been exemplified by a [cat event], which was invented by some of the members of our team. And turning that, using that mechanism, and exploiting that with a small molecule that could be oral to allow a formulation as both an on
Pharvaris NV at Cantor Fitzgerald Global Healthcare Conference Transcript
Sep 26, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers